FDA to act quickly on Moderna’s COVID vaccine bid for youngest kids

WASHINGTON, May 19 (Reuters) – The U.S. Food and Drug Administration will act as soon as possible on Moderna Inc’s (MRNA.O) application seeking approval of its COVID-19 vaccine for children under age 5, the agency’s chief told lawmakers on Thursday.

“There’s no delay in Moderna’s application,” FDA Commissioner Robert Califf told a U.S. House Agriculture subcommittee, adding the agency was preparing for public hearings on the company’s bid “as quickly as possible.”

FDA to act quickly on Moderna’s COVID vaccine bid for youngest kids -Califf | Reuters